COVID-19 vaccination and carditis in children and adolescents: a systematic review and meta-analysis

Oscar Hou In Chou1, Jonathan Mui1, Cheuk To Chung1

  • 1Epidemiology Research Unit, Cardiovascular Analytics Group, China-UK Collaboration, Hong Kong, China.

Insights

Carditis is a rare side effect of COVID-19 vaccination in young people, occurring at a rate of approximately 38 per million doses. Most cases are mild and resolve quickly, with higher rates observed in males and after the second dose.

Area of Science:

  • Cardiology
  • Vaccinology
  • Public Health

Background:

  • COVID-19 vaccination has been linked to carditis, particularly in pediatric males.
  • Global rates of post-vaccination carditis in children and adolescents require systematic investigation.

Purpose of the Study:

  • To conduct a systematic review and meta-analysis to determine the incidence of carditis in pediatric and adolescent populations following COVID-19 vaccination.

Main Methods:

  • Searched PubMed, Embase, and Latin American databases for relevant studies.
  • Extracted event counts and at-risk populations; calculated rate ratios per million doses.
  • Performed subgroup analysis based on vaccine dose and patient demographics.

Main Results:

  • Analyzed 39 studies involving 12,602,625 COVID-19 vaccine doses, identifying 343 carditis cases (pooled rate: 37.76/million).
  • Carditis rates were higher in males (rate ratio: 5.04) and after the second vaccine dose (rate ratio: 5.60).
  • Most cases (99.67%) resolved, with common symptoms including chest pain, ECG abnormalities, and myocardial edema on CMR.

Conclusions:

  • Post-COVID-19 vaccination carditis is rare in children and adolescents globally.
  • The majority of carditis episodes are self-limiting with rapid symptom resolution.
  • Balancing vaccine benefits against rare risks like carditis is crucial.
Abstract

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
14
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
25
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
20
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
23
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
18
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
14